Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MAP Pharmaceuticals looks to FDA for migraine treatment approval
MAP Pharmaceuticals looks to FDA for migraine treatment approval
MAP Pharmaceuticals looks to FDA for migraine treatment approval
Submitted by
admin
on May 28, 2011 - 2:02pm
Source:
Medreps
News Tags:
MAP Pharmaceuticals
Levadex
migraines
Headline:
MAP Pharmaceuticals looks to FDA for migraine treatment approval
Do Not Allow Advertisers to Use My Personal information
